10.59
-0.20
(-1.85%)
At close: January 10 at 3:59:59 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 3 | 2 |
| Avg. Estimate | 0.07 | 0.07 | 0.36 | 0.34 |
| Low Estimate | 0.07 | 0.07 | 0.32 | 0.3 |
| High Estimate | 0.07 | 0.07 | 0.4 | 0.38 |
| Year Ago EPS | 0.02 | 0.1 | 0.19 | 0.36 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 8 | 12 | 11 |
| Avg. Estimate | 287.96M | 285.86M | 1.13B | 1.19B |
| Low Estimate | 284M | 272.52M | 1.13B | 1.15B |
| High Estimate | 291.8M | 293M | 1.14B | 1.22B |
| Year Ago Sales | 278.23M | 275.81M | 1.05B | 1.13B |
| Sales Growth (year/est) | 3.50% | 3.65% | 7.20% | 5.29% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.05 | 0.06 | 0.05 | 0.06 |
| EPS Actual | 0.02 | 0.1 | 0.09 | 0.05 |
| Difference | -0.03 | 0.04 | 0.04 | -0.02 |
| Surprise % | -55.65% | 67.36% | 87.84% | -27.88% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.07 | 0.07 | 0.36 | 0.34 |
| 7 Days Ago | 0.08 | 0.06 | 0.34 | 0.34 |
| 30 Days Ago | 0.08 | 0.06 | 0.37 | 0.34 |
| 60 Days Ago | 0.06 | 0.06 | 0.3 | 0.3 |
| 90 Days Ago | 0.06 | 0.06 | 0.34 | 0.35 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GTII.CN | 243.14% | -30.00% | 88.06% | -6.42% |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Maintains | Wedbush: Outperform to Outperform | 5/10/2024 |
| Maintains | Needham: Buy to Buy | 5/9/2024 |
| Maintains | Needham: Buy to Buy | 2/29/2024 |
| Initiated | Zuanic & Associates: Overweight | 11/7/2023 |
| Reiterates | Needham: Buy | 5/4/2023 |
| Reiterates | Benchmark: Buy | 3/1/2023 |
Related Tickers
TRUL.CN Trulieve Cannabis Corp.
7.09
-2.88%
CURA.TO Curaleaf Holdings, Inc.
2.0600
-0.48%
CL.CN Cresco Labs Inc.
1.3500
-0.74%
AYR-A.CN Ayr Wellness Inc.
0.6400
-5.88%
VRNO.NE Verano Holdings Corp.
1.6900
-2.87%
TSND.TO TerrAscend Corp.
0.7900
-5.95%
CBST.NE The Cannabist Company Holdings Inc.
0.1000
0.00%
VRNOF Verano Holdings Corp.
1.1800
-3.28%
TLRY.TO Tilray Brands, Inc.
1.7500
-12.06%
JUSH.CN Jushi Holdings Inc.
0.4300
0.00%